Medicare Enrolled
Dr. Sarfraz Aly, MD
Internal Medicine · Sugar Land, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Aly from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Aly?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Aly
Dr. Sarfraz Aly is an internal medicine specialist in Sugar Land, TX, with 18 years of NPI registration. Based on federal Medicare data, Dr. Aly performed 24,033 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Aly received a total of $16,370 from 48 pharmaceutical and/or device companies across 548 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Aly is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years of NPI registration
▲ Top 2% volume in TX
$16,370 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗24,033
Medicare services
Top 2% in TX for internal medicine
Not available
Unique patients (not deduplicated)
$30
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Dalbavancin injection, 5 mg An injection of the antibiotic dalbavancin, administered in a 5 mg dose. |
8,500 | $11 | $40 |
| Inclisiran injection (Leqvio) for cholesterol | 7,952 | $9 | $34 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
4,761 | $60 | $200 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
700 | $95 | $253 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
676 | $131 | $388 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
318 | $98 | $275 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
200 | $113 | $354 |
| Nursing facility visit, established patient, straightforward A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves straightforward medical decision making and lasts at least 10 minutes. |
125 | $30 | $86 |
| Additional tissue removal, per 20 sq cm This code covers the removal of extra muscle or tissue in increments of 20 square centimeters or less. It is used to bill for additional areas treated beyond the initial procedure. |
116 | $41 | $143 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
97 | $88 | $206 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
95 | $123 | $327 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
94 | $90 | $300 |
| Skin and tissue removal, 20 sq cm or less This procedure involves the surgical excision of skin and underlying tissue from an area measuring 20 square centimeters or smaller. |
76 | $41 | $255 |
| Muscle or tissue removal, 20 sq cm or less This procedure involves the surgical removal of muscle or other tissue from the body. The total area of the removed tissue is 20.0 square centimeters or less. |
56 | $110 | $458 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
46 | $67 | $183 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
41 | $46 | $225 |
| New patient office visit, complex (60-74 min) | 40 | $150 | $432 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
36 | $11 | $48 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
29 | $41 | $103 |
| Removal of tunneled central venous tube This procedure involves the removal of a catheter that has been surgically placed under the skin and threaded into a large vein. |
23 | $126 | $328 |
| Home health plan of care re-certification A physician reviews the patient's status and contacts the home health agency to re-certify the plan of care without the patient being present. |
22 | $31 | $82 |
| Initial nursing facility care, moderate complexity Initial care provided to a patient in a nursing facility with moderate medical decision making, taking at least 35 minutes. |
18 | $102 | $251 |
| Nursing facility discharge management, more than 30 minutes This service involves care coordination and management activities performed by a healthcare professional to prepare a patient for discharge from a nursing facility. It requires more than 30 minutes of time spent on these activities. |
12 | $100 | $204 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.2% high complexity
68.6% medium
31.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$16,370
Total received (2018-2024)
Avg $2,339/year across 7 years
Top 6% in TX for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
548
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,956
2023
$1,092
2022
$1,459
2021
$976
2020
$1,662
2019
$1,521
2018
$3,704
Payments by company (2024)
ABBVIE INC.
$4,307
Smith+Nephew, Inc.
$358
MIMEDX Group, Inc.
$251
RedDress USA, Inc.
$242
ETS Wound Care LLC
$237
Merck Sharp & Dohme LLC
$159
Boston Scientific Corporation
$135
Kerecis Limited
$113
Melinta Therapeutics, LLC
$51
Organogenesis Inc.
$48
La Jolla Pharmaceutical Company
$22
Gilead Sciences, Inc.
$17
Urgo Medical North America, LLC
$17
Top 3 companies account for 82.5% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$4,598
Smith+Nephew, Inc.
$3,034
Osiris Therapeutics Inc.
$2,088
Smith & Nephew, Inc.
$766
Allergan Inc.
$533
AbbVie Inc.
$386
Merck Sharp & Dohme LLC
$365
Merck Sharp & Dohme Corporation
$356
Boston Scientific Corporation
$290
Melinta Therapeutics, Inc.
$253
MIMEDX Group, Inc.
$251
RedDress USA, Inc.
$242
ETS Wound Care LLC
$237
Paratek Pharmaceuticals, Inc.
$214
HARTMANN USA, INC.
$214
TETRAPHASE PHARMACEUTICALS, INC.
$213
Gilead Sciences, Inc.
$195
Silk Road Medical, Inc.
$183
ViiV Healthcare Company
$169
Melinta Therapeutics, LLC
$139
Allergan, Inc.
$133
Kerecis Limited
$130
Inari Medical, Inc.
$125
Novartis Pharmaceuticals Corporation
$125
E.R. Squibb & Sons, L.L.C.
$125
Insmed, Inc.
$121
Shionogi Inc
$112
Lilly USA, LLC
$76
Misonix Inc
$73
Organogenesis Inc.
$71
ConvaTec Inc.
$66
Cumberland Pharmaceuticals, Inc.
$58
Musculoskeletal Transplant Foundation Inc.
$53
KCI USA, Inc.
$45
ORGANOGENESIS INC.
$41
MAYNE PHARMA INC.
$40
Shire North American Group Inc
$37
Reapplix Inc.
$26
AstraZeneca Pharmaceuticals LP
$22
Janssen Biotech, Inc.
$22
La Jolla Pharmaceutical Company
$22
Theravance Biopharma, Inc.
$21
Dynavax Technologies Corporation
$21
Aroa Biosurgery Incorporated
$19
Urgo Medical North America, LLC
$17
Tactile Systems Technology Inc
$14
Fujirebio Diagnostics, Incorporated
$14
Abbott Laboratories
$13
Top 3 companies account for 59.4% of all-time payments
Associated products mentioned in payments ›
3C Patch Kit · 3M Cavilon · ACTIV.A.C. · ALLEVYN LIFE · APRETUDE · AQUACEL AG · AQUACEL Ag Advantage Surgical · AVELLE · AVYCAZ · Arikayce · Baxdela · CABENUVA · COLLAGENASE SANTYL · Confirm Rx · DALVANCE · DIFICID · DORYX · DOVATO · ELIQUIS · ENROUTE Transcarotid Neuroprotection System · ENTRESTO · EVUSHELD · EkoSonic · FLEXITOUCH · FLOWTRIEVER CATHETER · Fetroja · GATTEX · GRAFIX · GRAFIX PL · GRAFIX/GRAFIXPL/STRAVIX · Grafix PL PRIME · GrafixPL · Heplisav-B · ISENTRESS · Iodosorb Ointment 40g USA · Kerecis Omega3 SurgiClose · Kimyrsa · MAVYRET · MIRRAGEN ADVANCED WOUND MATRIX · MOUNJARO · NOXAFIL · NUZYRA · Oasis · PICO · PICO Single Use Negative Pressure Wound Therapy · PICO7 · PIFELTRO · Proximel · Puraply · RECARBRIO · REGRANEX · RENASYS · RENASYS GO v2 HOME · RENASYS TOUCH · Renasys · S · STRAVIX PL · SYMTUZA · Santyl · Stravix · TEFLARO · TheraSkin · Two Press · UBRELVY · URGOCLEAN AG · VIBATIV · Vabomere · Vibativ · XERAVA · Xerava · ZERBAXA · Zetuvit · Zetuvit Plus
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Internal medicine physicians in nearby ZIP areas
2,268
County median income
$113,409
Nearest hospital to ZIP centroid (approximate)
HOUSTON METHODIST SUGARLAND HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Aly is a mixed practice specialist, with above-average Medicare volume (top 2% in TX), with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Aly experienced with dalbavancin injection, 5 mg?
Based on Medicare claims data, Dr. Aly performed 8,500 dalbavancin injection, 5 mg services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Aly receive payments from pharmaceutical companies?
Yes. Dr. Aly received a total of $16,370 from 48 companies across 548 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Aly's costs compare to other internal medicine physicians in Sugar Land?
Dr. Aly's average Medicare payment per service is $30. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Aly) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Sugar Land
Browse internal medicine physicians in Sugar Land ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in TX
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in TX
Which TX internal medicine physicians receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Smith+Nephew, Inc. Payments to Doctors
See all physicians who received payments from Smith+Nephew, Inc.
By company
Osiris Therapeutics Inc. Payments to Doctors
See all physicians who received payments from Osiris Therapeutics Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology